XML 50 R36.htm IDEA: XBRL DOCUMENT v3.24.1
BUSINESS DESCRIPTION (Narrative) (Details) - USD ($)
3 Months Ended 12 Months Ended 36 Months Ended
Jun. 08, 2023
Apr. 14, 2023
Mar. 31, 2024
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2024
Jan. 19, 2024
Apr. 13, 2020
Business Acquisition [Line Items]                  
Net loss         $ 5,800,000        
Net cash used in operating activities         (3,559,000) $ (7,721,000)      
Accumulated deficit         (98,150,000) (92,297,000)      
Working capital         500,000        
Proceeds from issuance of common stock         2,245,000 129,000      
Gain on dissolution of the joint venture         $ 100,000        
Reverse stock split description         On September 21, 2023 we filed a Certificate of Amendment to our Third Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware, pursuant to which we effected a 1-for-20 reverse stock split (the “Reverse Stock Split”) of our issued and outstanding common stock. The Reverse Stock Split became effective as of 5:00 p.m. (Eastern Time) on September 21, 2023, and our common stock began trading on a split-adjusted basis on the Nasdaq Capital Market at the market open on September 22, 2023. Unless otherwise indicated, all share amounts, per share data, share prices, exercise prices and conversion rates set forth in these notes and the accompanying consolidated financial statements have, where applicable, been adjusted retroactively to reflect this reverse stock split        
Subsequent Events [Member]                  
Business Acquisition [Line Items]                  
Aggregate authorized offering price               $ 865,889  
Amount available for future sale of shares pursuant to the sales agreement               800,000  
AGP 2023 Sales Agreement                  
Business Acquisition [Line Items]                  
Aggregate authorized offering price   $ 5,800,000              
Proceeds from issuance of common stock   $ 100,000     $ 1,000        
Shares issued (in shares)   10,192     25        
Amount available for future sale of shares pursuant to the sales agreement         $ 3,700,000        
AGP 2023 Sales Agreement | Subsequent Events [Member]                  
Business Acquisition [Line Items]                  
Aggregate authorized offering price               865,889  
Amount available for future sale of shares pursuant to the sales agreement               $ 800,000  
AGP 2023 Sales Agreement | AGP                  
Business Acquisition [Line Items]                  
Shares issued (in shares)     10,167 10,189          
Payments of stock issuance costs       $ 2,000          
Securities purchase agreement                  
Business Acquisition [Line Items]                  
Proceeds from issuance of common stock $ 2,000,000.0                
Shares issued (in shares) 206,250                
Payments of stock issuance costs $ 200,000                
At The Market Offering Agreement | AGP                  
Business Acquisition [Line Items]                  
Aggregate authorized offering price                 $ 50,000,000.0
Proceeds from issuance of common stock         $ 500,000 $ 100,000 $ 15,600,000    
Shares issued (in shares)         30,827 4,251 260,128    
Payments of stock issuance costs             $ 500,000    
Maximum | AGP 2023 Sales Agreement                  
Business Acquisition [Line Items]                  
Aggregate authorized offering price   $ 5,800,000              
Maximum | AGP 2023 Sales Agreement | AGP                  
Business Acquisition [Line Items]                  
Proceeds from issuance of common stock     $ 100,000 $ 100,000